BCHE and Alzheimer disease: One such group of compounds, the cholinesterase inhibitors having the appropriate structure/activity profile were initially shown to be beneficial from a symptomatic cognitive standpoint but were unfortunately shown to provide little by way of evidence in support of their use for the prevention of the neuronal cell damage and death characteristic of AD.